Report of Foreign Issuer (6-k)
30 December 2014 - 1:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2014
Commission File Number:
001-34975
IMRIS
INC.
(Translation of registrant's name into English)
100-1370 Sony Place,
Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)
Indicate by check mark
whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
INCORPORATION BY REFERENCE
Exhibit 99.1 to this Form 6-K shall be incorporated
by reference as an exhibit to the Registration Statement of IMRIS Inc. on Form F-10 (File No. 333-183820).
DOCUMENTS FILED AS PART OF THIS FORM 6-K
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
IMRIS Inc. |
|
(Registrant) |
|
|
|
Date: December 24, 2014 |
By: |
/s/ Jay D. Miller |
|
|
_____________________________________ |
|
Name: |
Jay D. Miller |
|
Title: |
President, Chief Executive Officer and Director |
|
|
|
EXHIBIT INDEX
99.1 |
News Release dated December 24, 2014 - IMRIS Announces Closing of Private Placement Offering of Units |
Exhibit 99.1
IMRIS Announces Closing of Private Placement Offering of Units
MINNEAPOLIS, Dec. 24, 2014 /CNW/ - IMRIS Inc. (NASDAQ:
IMRS; TSX: IM) ("IMRIS" or the "Company") today announced it has closed the private placement offering of 10,563,380
units at an offering price of US$0.284 per unit. Each unit (the "Units") consists of one common share of the Company
(the "Common Shares") and one and a quarter common share purchase warrants (the "Warrants"). Each whole
Warrant is exercisable into one Common Share during the period starting on the day that is four months from the date of issue and
ending on the day that is five and a half years from the date of issue at an exercise price per common share of US$0.3692.
The gross proceeds to IMRIS in connection with the offering are US$3.0 million.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing
image guided therapy solutions through its VISIUS Surgical Theatre – a revolutionary, multifunctional surgical environment
that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The
multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating
room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been
selected by 61 leading medical institutions around the world.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain or refer to forward-looking
information based on current expectations, including but not limited to statements or assumptions about IMRIS' ability to collect
accounts receivable expediently or at all, IMRIS' growth prospects, and any other statements regarding the IMRIS' objectives (and
strategies to achieve such objectives), future expectations, beliefs, goals or prospects. In some cases, forward-looking statements
can be identified by terminology such as "anticipate", "may", "expect", "believe", "prospective",
"continue" or the negative of these terms or other similar expressions concerning matters that are not historical facts.
These statements should not be understood as guarantees of future performance or results. Such statements involve known and unknown
risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from
those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance
that actual results will be consistent with such statements. Forward-looking statements are subject to significant risks and uncertainties,
and other factors that could cause actual results to differ materially from expected results. These forward looking statements
are made as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances.
SOURCE IMRIS Inc.
%CIK: 0001489161
For further information: Jeffery Bartels, Director-Finance,
IMRIS Inc., Tel: 763-203-6328, Email: jbartels@imris.com
CO: IMRIS Inc.
CNW 11:57e 24-DEC-14
Imris (CE) (USOTC:IMRSQ)
Historical Stock Chart
From May 2024 to Jun 2024
Imris (CE) (USOTC:IMRSQ)
Historical Stock Chart
From Jun 2023 to Jun 2024